Literature DB >> 21709694

Chemotherapy: Have a break.

M Teresa Villanueva.   

Abstract

Year:  2011        PMID： 21709694     DOI： 10.1038/nrclinonc.2011.98

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Authors:  Richard A Adams; Angela M Meade; Matthew T Seymour; Richard H Wilson; Ayman Madi; David Fisher; Sarah L Kenny; Edward Kay; Elizabeth Hodgkinson; Malcolm Pope; Penny Rogers; Harpreet Wasan; Stephen Falk; Simon Gollins; Tamas Hickish; Eric M Bessell; David Propper; M John Kennedy; Richard Kaplan; Timothy S Maughan
Journal:  Lancet Oncol       Date:  2011-06-05       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.